Evidence-based prescription drug coverage

被引：1

作者：

Diamond, GA ^{[1
]}

Wetzler, HP ^{[1
]}

机构：

[1] Cedars Sinai Med Ctr, Div Cardiol, Los Angeles, CA 90048 USA

来源：

AMERICAN JOURNAL OF CARDIOLOGY | 2001年 / 88卷 / 07期

关键词：

D O I：

10.1016/S0002-9149(01)01929-4

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Instead of the fixed discounts that characterize most prescription drug coverage proposals, we should craft a plan that scales the discount in direct proportion to each drug's proven therapeutic benefit. Evidence-based discounting would thereby encourage pharmaceutical companies to develop more beneficial drugs, would induce doctors to prescribe them, and would make it easier for patients to afford them.

引用

页码：767 / +

页数：2